Actively Recruiting
Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
Led by Hospital Universitari de Bellvitge · Updated on 2025-04-29
20
Participants Needed
1
Research Sites
105 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia
CONDITIONS
Official Title
Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of classical or idiopathic trigeminal neuralgia according to International Classification of Headache Disorders (ICHD-3) criteria
- Age over 18 years
- Signed informed consent
- Presentation to the emergency department of Hospital de Bellvitge for acute pain exacerbation
- Prescribed intravenous lacosamide for symptomatic pain treatment as decided by treating physician
You will not qualify if you...
- Contraindication for lacosamide treatment (previous hypersensitivity, known atrioventricular block)
- Mental or psychiatric illness interfering with consent understanding and signing
- Language barrier
- Lack of cooperation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hospital de Bellvitge
L'Hospitalet de Llobregat, Barcelona, Spain, 08907
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here